Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Clinical trial NCT02683824 · COMPLETED
Trial details
- NCT number
- NCT02683824
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-12
- Primary completion
- 2021-09-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.